Adult Stem Cells Used in Clinical Trial for Heart Failure
The U.S. adult stem cell company Bioheart has announced positive results from its clinical trial in the treatment of heart failure with adult stem cells.
The U.S. adult stem cell company Bioheart has announced positive results from its clinical trial in the treatment of heart failure with adult stem cells.
Scientists at the Scripps Research Institute have successfully reversed a rare genetic disorder with autologous adult stem cell therapy.
Fluidigm has announced the design of an "integrated fluidic circuit" chip for the culturing of stem cells.
Among this year’s recipients of the Lasker Awards are Dr. Shinya Yamanaka of Kyoto University in Japan and Dr. John Gurdon of Cambridge University in England.
The U.S. company Stem Cell Therapy International and the S. Korean company Histostem today announced the terms of a litigation settlement.
The U.S. company Neuralstem receives yet another patent for its novel adult stem cell technology.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.